ATF1 was found to be over-expressed in several cancer types including lymphoma, melanoma and nasopharyngeal carcinoma, and functioned as a tumor promoter both in vitro and in vivo31–34. This evidence concerns the gene ATF1 and nasopharyngeal carcinoma.